FDANonrulemakingFDA-2026-N-5479
Who commented on this docket
Testosterone Use in Menopausal Women; Public Workshop
13 organizations filed 13 public comments on Testosterone Use in Menopausal Women; Public Workshop, at the Food and Drug Administration. The comment window closed 17d ago.
Organizations
13
Comments
13
RIN
—
Comment window
closed 17d ago
Abstract
OPEN
Commenters (13)
- Acrux DDS Pty Ltdunverified attribution1 filing · confidence 70%
- Adelaide Universityunverified attribution1 filing · confidence 70%
- Ailse Oncology Ltd.unverified attribution1 filing · confidence 70%
- American Association of Clinical Endocrinologytrade assoc.1 filing · confidence 85%
- Health Without Risk LLCunverified attribution1 filing · confidence 70%
- Hims & Hers Health Inc.unverified attribution1 filing · confidence 70%
- International Society for the Study of Women's Sexual Healthtrade assoc.1 filing · confidence 85%
- LIPOCINE INC.unverified attribution1 filing · confidence 70%
- National Community Pharmacists Associationtrade assoc.1 filing · confidence 97%
- PharmedOut at Georgetown University Medical Centerunverified attribution1 filing · confidence 70%
- RRM Foundationtrade assoc.1 filing · confidence 85%
- The Netherlands Association for Women's Intereststrade assoc.1 filing · confidence 85%
- The Netherlands Association for Women's Interests Women's Work and Equal Citizenshiptrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.